HCWB is trading at $2.23, down 8% in after-hours action as the stock eases off a 129.25% surge recorded during the prior regular session.
- The pullback appears to be driven by profit-taking and price normalization following extreme speculative momentum in the volatile micro-cap biotech.
- Multiple sources confirm there are no new company-specific headlines, regulatory filings, or fundamental changes to account for the recent price swings.